FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009134026> ?p ?o ?g. }

• W2009134026 endingPage "2011" @default.
• W2009134026 startingPage "2010" @default.
• W2009134026 abstract "The study by Kobayasi et al (1) links endothelial dysfunction resulting from high-fat diet-induced obesity to oxidative stress and vascular inflammation that involves a reduction in endogenous antioxidant mechanisms and activation of NFκB. Thus, the reduction of acetylcholine-induced vasorelaxation was associated with reduced vascular expression of eNOS, SOD and IκB but increased expression of TNFα. Blood glucose levels were increased almost 2-fold and blood pressure was elevated in response to a high-fat diet.Although it is well-established that diabetes and obesity are conditions of oxidative stress that predispose to cardiovascular disease, the use of antioxidant therapies to prevent or delay the onset of cardiovascular complications has been disappointing (2). Moreover, the epidemic increase in obesity and metabolic syndrome predates an overwhelming increase in cardiovascular disease without the advent of effective therapies. The results of the current study suggest that anti-inflammatory strategies that target NFκB in addition to antioxidant therapy may provide a potential avenue for investigation as both SOD and inhibition of NFκB with sodium salicylate corrected the defect in endothelium-dependent vasorelaxation in mice maintained on a high-fat diet for 16 weeks. It would have been of interest to address the effect of antioxidant treatment in vivo on endothelial function and the levels of inflammatory markers, especially in light of a recent study showing that tempol treatment of WKY and SHR rats maintained on a high-fat diet prevented endothelial dysfunction (3). Similarly, it would be of interest to determine whether in vivo treatment with sodium salicylate prevents or reverses endothelial dysfunction and the associated oxidative stress and inflammation in this model. Thus, the sequence of events leading to the development of endothelial dysfunction as it relates to activation of NFκB, inflammation and oxidative stress has not been elucidated. As the authors discuss, NFκB regulates transcription of genes for inflammatory cytokines but, in turn, may, also, be activated by cytokines such as TNFα, which was increased in obese mice compared to lean mice. For example, DOCA-salt induced-hypertension in the rat was associated with increased renal NFκB activity, which was reduced by an inhibitor of TNFα (4).A puzzling aspect of this study is the immediacy of the reversal of endothelial dysfunction by sodium salicylate, which was used as an inhibitor of NFκB. Thus, aortic rings from mice maintained on a high-fat diet were incubated with sodium salicylate for 60 minutes, which was sufficient to restore vasorelaxant responses to acetylcholine (1). It is difficult to envisage how inhibition/removal of a transcription factor would affect downstream events so rapidly unless the effects of sodium salicylate do not only relate to inhibition of NFκB. The results with SOD, which does not enter cells unless conjugated to polyethylene glycol, suggest that extracellular superoxide interacts with endothelium-derived nitric oxide, presumably in the sub-endothelial space, to reduce its bioavailability at the vascular smooth muscle. As SOD and sodium salicylate produce essentially similar effects in correcting the response to acetylcholine in the aortae from obese mice, the possibility that sodium salicylate reduces superoxide levels either directly or indirectly should be considered.An alternative explanation for the effect of sodium salicylate to correct the impaired endothelium-dependent vascular responses of aortic rings from mice fed a high-fat diet may relate to inhibition of cyclo-oxygenase as the endothelium can produce contracting factors such as prostaglandin endoperoxides and thromboxane A2 (5). Although this is an unlikely possibility given the relative lack of potency of sodium salicylate as an inhibitor of cyclo-oxygenase, it was used at a high concentration, 5mM, in this study. The authors cite studies that indicate that the effect of salicylate is unrelated to inhibition of cyclo-oxygenase, a possibility that would have been excluded if indomethacin, for example, was without effect on relaxant responses. Thus, Traupe et al (2001) reported increased cyclo-oxygenase-dependent contractile responses to acetylcholine and increased vascular expression of thromboxane receptors in mice made obese by high dietary fat (6). Moreover, oxidative stress has been shown to increase COX-2 expression in a number of cell types including endothelial cells (7) and vascular smooth muscle cells (8) and salicylate has been reported to inhibit COX-2 expression (9), perhaps an effect via inhibition of NFκB. However, in order to clarify the contribution of NFκB in the endothelial dysfunction associated with obesity, the use of selective inhibitors should be employed.It is of clinical significance that endothelial dysfunction, considered an early indicator for the development of cardiovascular disease of multiple etiologies including obesity and diabetes (10, 11), can be acutely reversed after 16 weeks of a high-fat diet. Similarly, a recent study by Ketonen at al (2010) found that caloric restriction reversed endothelial dysfunction in mice fed a high-fat diet for up to 150days and this effect was associated with a reduction of vascular oxidative stress. This group, also, reported that the impairment in endothelium-dependent vasorelaxation after 8 months of a high-fat diet, which was associated with increased production of pro-inflammatory cytokines, was corrected upon removal of periadventitial fat or by reducing oxidative stress (13). This study supports the results of Kobayasi et al. (1) implicating oxidative stress and inflammation in endothelial dysfunction but indicates that periadventitial fat is the source of both the oxidative stress and vascular inflammation. Importantly, both studies indicate a lack of irreversible changes even after 8 months of a high-fat diet, indicating that corrective measures may be implemented long after the appearance of endothelial dysfunction. Presumably, restoration of normal vascular function would occur if the high-fat diet is replaced by a standard murine diet.The present study (1) confirms the results of other studies showing that obesity is a condition of oxidative stress associated with vascular inflammation and impaired vasorelaxant responses to acetylcholine (12, 14). The major new findings relate to the potential contribution of activation of NFκB, supporting the findings of Pierce et al. (2009) in obese humans in which a putative inhibitor of NFκB improved flow-mediated dilation and reduced oxidative stress. The results of these studies should provide the impetus for studies to elucidate the contribution of NFκB to endothelial dysfunction and for long-term animal studies of inhibitors of NFκB, alone and in combination with antioxidants, on the development of cardiovascular and renal disease associated with obesity, metabolic syndrome and diabetes." @default.
• W2009134026 created "2016-06-24" @default.
• W2009134026 creator A5046908555 @default.
• W2009134026 date "2010-10-01" @default.
• W2009134026 modified "2023-10-18" @default.
• W2009134026 title "Oxidative stress and inflammation in the endothelial dysfunction of obesity: a role for nuclear factor kappa B?" @default.
• W2009134026 cites W1982811953 @default.
• W2009134026 cites W1983537588 @default.
• W2009134026 cites W1987157579 @default.
• W2009134026 cites W2006566461 @default.
• W2009134026 cites W2008044198 @default.
• W2009134026 cites W2065480603 @default.
• W2009134026 cites W2074390557 @default.
• W2009134026 cites W2075609371 @default.
• W2009134026 cites W2094145597 @default.
• W2009134026 cites W2120660504 @default.
• W2009134026 cites W2126624423 @default.
• W2009134026 cites W2139130558 @default.
• W2009134026 cites W2160375807 @default.
• W2009134026 cites W2167563726 @default.
• W2009134026 cites W77401854 @default.
• W2009134026 doi "https://doi.org/10.1097/hjh.0b013e32833e24cb" @default.
• W2009134026 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2945251" @default.
• W2009134026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20844369" @default.
• W2009134026 hasPublicationYear "2010" @default.
• W2009134026 type Work @default.
• W2009134026 sameAs 2009134026 @default.
• W2009134026 citedByCount "12" @default.
• W2009134026 countsByYear W20091340262014 @default.
• W2009134026 countsByYear W20091340262015 @default.
• W2009134026 countsByYear W20091340262016 @default.
• W2009134026 countsByYear W20091340262019 @default.
• W2009134026 countsByYear W20091340262020 @default.
• W2009134026 countsByYear W20091340262022 @default.
• W2009134026 crossrefType "journal-article" @default.
• W2009134026 hasAuthorship W2009134026A5046908555 @default.
• W2009134026 hasBestOaLocation W20091340261 @default.
• W2009134026 hasConcept C126322002 @default.
• W2009134026 hasConcept C138885662 @default.
• W2009134026 hasConcept C2776151105 @default.
• W2009134026 hasConcept C2776914184 @default.
• W2009134026 hasConcept C2778724333 @default.
• W2009134026 hasConcept C2780972559 @default.
• W2009134026 hasConcept C41895202 @default.
• W2009134026 hasConcept C511355011 @default.
• W2009134026 hasConcept C71924100 @default.
• W2009134026 hasConceptScore W2009134026C126322002 @default.
• W2009134026 hasConceptScore W2009134026C138885662 @default.
• W2009134026 hasConceptScore W2009134026C2776151105 @default.
• W2009134026 hasConceptScore W2009134026C2776914184 @default.
• W2009134026 hasConceptScore W2009134026C2778724333 @default.
• W2009134026 hasConceptScore W2009134026C2780972559 @default.
• W2009134026 hasConceptScore W2009134026C41895202 @default.
• W2009134026 hasConceptScore W2009134026C511355011 @default.
• W2009134026 hasConceptScore W2009134026C71924100 @default.
• W2009134026 hasIssue "10" @default.
• W2009134026 hasLocation W20091340261 @default.
• W2009134026 hasLocation W20091340262 @default.
• W2009134026 hasLocation W20091340263 @default.
• W2009134026 hasLocation W20091340264 @default.
• W2009134026 hasOpenAccess W2009134026 @default.
• W2009134026 hasPrimaryLocation W20091340261 @default.
• W2009134026 hasRelatedWork W1574459634 @default.
• W2009134026 hasRelatedWork W1710984564 @default.
• W2009134026 hasRelatedWork W2027456987 @default.
• W2009134026 hasRelatedWork W2053989737 @default.
• W2009134026 hasRelatedWork W2369476033 @default.
• W2009134026 hasRelatedWork W2902383751 @default.
• W2009134026 hasRelatedWork W2999571836 @default.
• W2009134026 hasRelatedWork W3176367938 @default.
• W2009134026 hasRelatedWork W4283642255 @default.
• W2009134026 hasRelatedWork W4303579210 @default.
• W2009134026 hasVolume "28" @default.
• W2009134026 isParatext "false" @default.
• W2009134026 isRetracted "false" @default.
• W2009134026 magId "2009134026" @default.
• W2009134026 workType "article" @default.